Less than one month after NuPathe’s (Nasdaq: PATH) board approved an acquisition offer by Endo Health Solutions, (Nasdaq: ENDP) the specialty pharmaceutical company has unexpectedly found itself at the center of what could be a bidding war after receiving another offer in a surprising development in life science industry news. Big pharma company Teva (NYSE: […]
The leadership change at NuPathe (NASDAQ:PATH) has ushered in a CEO with the sales and marketing background to bring its first product — a migraine patch — to market, a move that is likely to loosen up the purse strings of conservative investors. Tracy T. Lefteroff, managing partner of the venture capital practice at PricewaterhouseCoopers, […]
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Biopharmaceutical firm NuPathe’s (NASDAQ:PATH) CEO Jane Hollingsworth has resigned as CEO and board member of the company she co-founded more than six years ago. She has been replaced by the former CEO of Auxilium Pharmaceuticals (NASDAQ:AUXL), another company Hollingsworth co-founded. The move comes as NuPathe gears up to commercialize its lead product the Zelrix […]
NuPathe (NASDAQ:PATH), a biopharmaceutical company, has resubmitted a new drug application for its migraine patch to the U.S. Food and Drug Administration after resolving issues raised in a complete response letter last year. The Zelrix transdermal patch is designed to transmit sumatriptan via electrical charge through the skin in a drug-delivery method known as iontophoresis. […]
NuPathe (NASDAQ: PATH) said it will resubmit a new drug application for its transdermal migraine patch for approval by the U.S. Food and Drug Administration after receiving a complete response letter from the regulator, according to the company’s third quarter earnings report. NuPathe said the issues raised in the August 29 letter from the FDA […]
Highlights of the important and the interesting from the world of healthcare: Has the iPad been a disappointment for healthcare? Doubt any promise you hear about the iPad having a huge impact on the way healthcare is delivered–at least for now, writes Sandra Yin. Some of the breathless articles fawning over the device have overyped […]
Highlights of the important and the interesting from the world of healthcare: Return of the public option? Don’t bet on it: Nearly 130 House Democrats are pushing to restore the once-proposed “public option“–essentially a government-run health plan. Fueling the drive is a report from the Congressional Budget Office that said a public option would shave […]